Back to search
Membranous Nephropathy - PLA2R Induced
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Membranous Nephropathy - PLA2R Induced trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Membranous Nephropathy - PLA2R Induced trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Objective: To assess the disappearance rate (half-life) of anti-PLA2R antibodies in high-risk primary membranous nephropathy (pMN) patients treated with obinutu…
This study is a single-center, open-label, dose-escalation exploratory clinical trial, expected to enroll 6 to 12 participants. It will use a BOIN (Bayesian Opt…
The aim of this observational study is to provide analysis of T and B lymphocyte subgroups in peripheral blood samples of patients with primary membranous nephr…
This exploratory study aims to assess the efficacy, safety of the experimental treatment based on a combination of rituximab (RTX), intravenous (IV) cyclophosph…